BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 16683163)

  • 21. WNKs: protein kinases with a unique kinase domain.
    Huang CL; Cha SK; Wang HR; Xie J; Cobb MH
    Exp Mol Med; 2007 Oct; 39(5):565-73. PubMed ID: 18059132
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Familial hyperkalemic hypertension: phenotypic analysis in a large family with the WNK1 deletion mutation.
    Achard JM; Warnock DG; Disse-Nicodème S; Fiquet-Kempf B; Corvol P; Fournier A; Jeunemaitre X
    Am J Med; 2003 Apr; 114(6):495-8. PubMed ID: 12727582
    [No Abstract]   [Full Text] [Related]  

  • 23. Properties of WNK1 and implications for other family members.
    Lenertz LY; Lee BH; Min X; Xu BE; Wedin K; Earnest S; Goldsmith EJ; Cobb MH
    J Biol Chem; 2005 Jul; 280(29):26653-8. PubMed ID: 15883153
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impaired degradation of WNK1 and WNK4 kinases causes PHAII in mutant KLHL3 knock-in mice.
    Susa K; Sohara E; Rai T; Zeniya M; Mori Y; Mori T; Chiga M; Nomura N; Nishida H; Takahashi D; Isobe K; Inoue Y; Takeishi K; Takeda N; Sasaki S; Uchida S
    Hum Mol Genet; 2014 Oct; 23(19):5052-60. PubMed ID: 24821705
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kelch-like 3/Cullin 3 ubiquitin ligase complex and WNK signaling in salt-sensitive hypertension and electrolyte disorder.
    Sohara E; Uchida S
    Nephrol Dial Transplant; 2016 Sep; 31(9):1417-24. PubMed ID: 26152401
    [TBL] [Abstract][Full Text] [Related]  

  • 26. WNK1-related Familial Hyperkalemic Hypertension results from an increased expression of L-WNK1 specifically in the distal nephron.
    Vidal-Petiot E; Elvira-Matelot E; Mutig K; Soukaseum C; Baudrie V; Wu S; Cheval L; Huc E; Cambillau M; Bachmann S; Doucet A; Jeunemaitre X; Hadchouel J
    Proc Natl Acad Sci U S A; 2013 Aug; 110(35):14366-71. PubMed ID: 23940364
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of 108 SNPs in TSC, WNK1, and WNK4 and their association with hypertension in a Japanese general population.
    Kokubo Y; Kamide K; Inamoto N; Tanaka C; Banno M; Takiuchi S; Kawano Y; Tomoike H; Miyata T
    J Hum Genet; 2004; 49(9):507-515. PubMed ID: 15309683
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of ROMK channel and K+ homeostasis by kidney-specific WNK1 kinase.
    Liu Z; Wang HR; Huang CL
    J Biol Chem; 2009 May; 284(18):12198-206. PubMed ID: 19244242
    [TBL] [Abstract][Full Text] [Related]  

  • 29. WNK1 regulates phosphorylation of cation-chloride-coupled cotransporters via the STE20-related kinases, SPAK and OSR1.
    Moriguchi T; Urushiyama S; Hisamoto N; Iemura S; Uchida S; Natsume T; Matsumoto K; Shibuya H
    J Biol Chem; 2005 Dec; 280(52):42685-93. PubMed ID: 16263722
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathogenesis of pseudohypoaldosteronism type 2 by WNK1 mutations.
    Bergaya S; Vidal-Petiot E; Jeunemaitre X; Hadchouel J
    Curr Opin Nephrol Hypertens; 2012 Jan; 21(1):39-45. PubMed ID: 22080857
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanism of regulation of renal ion transport by WNK kinases.
    Huang CL; Yang SS; Lin SH
    Curr Opin Nephrol Hypertens; 2008 Sep; 17(5):519-25. PubMed ID: 18695394
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kelch-like 3 and Cullin 3 regulate electrolyte homeostasis via ubiquitination and degradation of WNK4.
    Shibata S; Zhang J; Puthumana J; Stone KL; Lifton RP
    Proc Natl Acad Sci U S A; 2013 May; 110(19):7838-43. PubMed ID: 23576762
    [TBL] [Abstract][Full Text] [Related]  

  • 33. WNK1 affects surface expression of the ROMK potassium channel independent of WNK4.
    Cope G; Murthy M; Golbang AP; Hamad A; Liu CH; Cuthbert AW; O'Shaughnessy KM
    J Am Soc Nephrol; 2006 Jul; 17(7):1867-74. PubMed ID: 16775035
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A unifying mechanism for WNK kinase regulation of sodium-chloride cotransporter.
    Huang CL; Cheng CJ
    Pflugers Arch; 2015 Nov; 467(11):2235-41. PubMed ID: 25904388
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pseudohypoaldosteronism Type II: A Young Girl Presented with Hypertension, Hyperkalemia and Metabolic Acidosis.
    Sethar GH; Almoghawi A; Khan N; Altourah W; Ashour NM
    J Coll Physicians Surg Pak; 2018 Mar; 28(3):S21-S22. PubMed ID: 29482694
    [TBL] [Abstract][Full Text] [Related]  

  • 36. WNK1 and WNK4 modulate CFTR activity.
    Yang CL; Liu X; Paliege A; Zhu X; Bachmann S; Dawson DC; Ellison DH
    Biochem Biophys Res Commun; 2007 Feb; 353(3):535-40. PubMed ID: 17194447
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The thiazide-sensitive Na-Cl cotransporter is regulated by a WNK kinase signaling complex.
    Yang CL; Zhu X; Ellison DH
    J Clin Invest; 2007 Nov; 117(11):3403-11. PubMed ID: 17975670
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of WNK4 and WNK1 kinase and inhibiting activities.
    Wang Z; Yang CL; Ellison DH
    Biochem Biophys Res Commun; 2004 May; 317(3):939-44. PubMed ID: 15081430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular pathogenesis of inherited hypertension with hyperkalemia: the Na-Cl cotransporter is inhibited by wild-type but not mutant WNK4.
    Wilson FH; Kahle KT; Sabath E; Lalioti MD; Rapson AK; Hoover RS; Hebert SC; Gamba G; Lifton RP
    Proc Natl Acad Sci U S A; 2003 Jan; 100(2):680-4. PubMed ID: 12515852
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.